JavaScript NENÍ povolen !

Prosím povolte JavaScript.

* Zobrazit nápovědu

Autor: Panayiotidis, Panayiotis ORCID: Panayiotidis, Panayiotis | 0000000303873993

1 záznamů v Medvik Filtry

Článek

Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy

Wei, Andrew H
Autor Wei, Andrew H ORCID The Peter MacCallum Cancer Centre, Royal Melbourne Hospital and Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia
Panayiotidis, Panayiotis
Autor Panayiotidis, Panayiotis ORCID National and Kapodistrian University of Athens Medical School, Laiko General Hospital, Athens, Greece
Montesinos, Pau
Autor Montesinos, Pau ORCID Hospital Universitario y Politécnico La Fe, Valencia, Spain and CIBERONC, Instituto Carlos III, Madrid, Spain
Laribi, Kamel
Autor Laribi, Kamel Centre Hospitalier-Le Mans, Le Mans, France
Ivanov, Vladimir
Autor Ivanov, Vladimir ORCID Almazov National Medical Research Center, Saint Petersburg, Russia
Kim, Inho
Autor Kim, Inho Seoul National University Hospital, Seoul, Republic of Korea
Novak, Jan
Autor Novak, Jan Department of Internal Medicine and Hematology, University Hospital Královské Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic
Champion, Rebecca
Autor Champion, Rebecca Norton Cancer Institute, Louisville, KY
Fiedler, Walter
Autor Fiedler, Walter Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Pagoni, Maria
Autor Pagoni, Maria Evaggelismos General Hospital, Athens Greece

Blood. 2022 ; 140 (25) : 2754-2756. [pub] 2022Dec22

ISSN 1528-0020
Medvik
Zdroj

MeSH
akutní myeloidní leukemie * farmakoterapie etiologie MeSH
cytarabin MeSH
lidé MeSH
následné studie MeSH
protokoly antitumorózní kombinované chemoterapie MeSH
Check Tag
lidé MeSH
Publikační typ
časopisecké články MeSH
práce podpořená grantem MeSH